SYNTHENA AG has a total of 19 patent applications. It increased the IP activity by 75.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are WAVE LIFE SCIENCES LTD, TRIPLEX PHARMA CORP and GUANGZHOU RIBOBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Sugars | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Enzymes | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Dugovic Branislav | 14 |
#2 | Renner Wolfgang Andreas | 10 |
#3 | Bertolini Reto | 10 |
#4 | Garcia Luis | 5 |
#5 | Avril Aurélie | 3 |
#6 | Avril Aurelie | 2 |
Publication | Filing date | Title |
---|---|---|
WO2019142135A1 | Tricyclo-dna nucleoside precursors and processes for preparing the same | |
US2020390792A1 | Modified oligomeric compounds comprising tricyclo-dna nucleosides and uses thereof | |
WO2018193428A1 | Modified oligomeric compounds comprising tricyclo-dna nucleosides and uses thereof | |
CA3037663A1 | Mixed tricyclo-dna, 2'-modified-rna oligonucleotide compositions and uses thereof | |
WO2018055577A1 | Mixed tricyclo-dna, 2'-modified rna oligonucleotide compositions and uses thereof | |
WO2015036451A1 | Nucleic acids and methods for the treatment of pompe disease |